News

Adragos Pharma Announces Swissmedic Approval for State-of-the-Art Manufacturing Line

Courroux, Switzerland – Wednesday, 21 January, 2026 Adragos Pharma, a leader in the CDMO industry, is pleased to announce it has received formal approval from the Swiss Agency for Therapeutic Products (Swissmedic) for their newly modernized sterile manufacturing suite, the […]

Adragos Pharma Expands in Japan: Boosting Production & Trust

We have been featured in Yakuji Nippo for its expansion in Japan and investment in the Kawagoe site to boost solid dosage production. The article highlights the company’s focus on quality, transparency, and its commitment to strengthening Japan’s pharmaceutical supply […]

Subscribe to our newsletter!

Get notified on our latest news.